Abstract:The gut microbiome has emerged as an important factor affecting human health and disease. The recent development of –omics approaches, including phylogenetic marker-based microbiome profiling, shotgun metagenomics, metatranscriptomics, metaproteomics, and metabolomics, has enabled efficient characterization of microbial communities. These techniques can provide strain-level taxonomic resolution of the taxa present in microbiomes, assess the potential functions encoded by the microbial community and quantify the metabolic activities occurring within a complex microbiome. The application of these meta-omics approaches to clinical samples has identified microbial species, metabolic pathways, and metabolites that are associated with the development and treatment of human diseases. These findings have further facilitated microbiome-targeted drug discovery and efforts to improve human health management. Recent in vitro and in vivo investigations have uncovered the presence of extensive drug-microbiome interactions. These interactions have also been shown to be important contributors to the disparate patient responses to treatment that are often observed during disease therapy. Therefore, developing techniques or frameworks that enable rapid screening, detailed evaluation, and accurate prediction of drug/host-microbiome interactions is critically important in the modern era of microbiome research and precision medicine. Here we review the current status of meta-omics techniques, including integrative multi-omics approaches, for characterizing the microbiome's functionality in the context of health and disease. We also summarize and discuss new frameworks for applying meta-omics approaches and microbiome assays to study drug-microbiome interactions. Lastly, we discuss and exemplify strategies for implementing microbiome-based precision medicines using these meta-omics approaches and high throughput microbiome assays.

Small molecules in the big picture of gut microbiome-host cross-talk

Metabolite interactions between host and microbiota during health and disease: Which feeds the other?

The Role of Gut Microbiota Associated Metabolites in Digestive Disorders

Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era

Interplays between drugs and the gut microbiome

Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.

Chemical genetic approaches to dissect microbiota mechanisms in health and disease

Gut microbiome and health: mechanistic insights

Gut microbiome-host interactions in health and disease

Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation

Gut microbial metabolites as multi-kingdom intermediates

Dietary compounds in modulation of gut microbiota-derived metabolites

Microbial Metabolites Determine Host Health and the Status of Some Diseases

Integrating the gut microbiome and pharmacology

The role of the gut microbiome and its metabolites in metabolic diseases

Advancing functional and translational microbiome research using meta-omics approaches

Implications of Gut Microbiota in Complex Human Diseases

Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives

The Influence of Gut Microbiota on Drug Metabolism and Toxicity.

Gut commensals and their metabolites in health and disease

Microbial metabolites as modulators of host physiology